Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
Background:
Serological (antibody detection) tests for tuberculosis (TB) are widely used in developing countries. As part of a World Health Organization policy process, we performed an updated systematic review to assess the diagnostic accuracy of commercial serological tests for pulmonary and extrapulmonary TB with a focus on the relevance of these tests in low- and middle-income countries.
Methods and Findings:
We used methods recommended by the Cochrane Collaboration and GRADE approach for rating quality of evidence. In a previous review, we searched multiple databases for papers published from 1 January 1990 to 30 May 2006, and in this update, we add additional papers published from that period until 29 June 2010. We prespecified subgroups to address heterogeneity and summarized test performance using bivariate random effects meta-analysis. For pulmonary TB, we included 67 studies (48% from low- and middle-income countries) with 5,147 participants. For all tests, estimates were variable for sensitivity (0% to 100%) and specificity (31% to 100%). For anda-TB IgG, the only test with enough studies for meta-analysis, pooled sensitivity was 76% (95% CI 63%–87%) in smear-positive (seven studies) and 59% (95% CI 10%–96%) in smear-negative (four studies) patients; pooled specificities were 92% (95% CI 74%–98%) and 91% (95% CI 79%–96%), respectively. Compared with ELISA (pooled sensitivity 60% [95% CI 6%–65%]; pooled specificity 98% [95% CI 96%–99%]), immunochromatographic tests yielded lower pooled sensitivity (53%, 95% CI 42%–64%) and comparable pooled specificity (98%, 95% CI 94%–99%). For extrapulmonary TB, we included 25 studies (40% from low- and middle-income countries) with 1,809 participants. For all tests, estimates were variable for sensitivity (0% to 100%) and specificity (59% to 100%). Overall, quality of evidence was graded very low for studies of pulmonary and extrapulmonary TB.
Conclusions:
Despite expansion of the literature since 2006, commercial serological tests continue to produce inconsistent and imprecise estimates of sensitivity and specificity. Quality of evidence remains very low. These data informed a recently published World Health Organization policy statement against serological tests.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis. PLoS Med 8(8): e32767. doi:10.1371/journal.pmed.1001062
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001062
Souhrn
Background:
Serological (antibody detection) tests for tuberculosis (TB) are widely used in developing countries. As part of a World Health Organization policy process, we performed an updated systematic review to assess the diagnostic accuracy of commercial serological tests for pulmonary and extrapulmonary TB with a focus on the relevance of these tests in low- and middle-income countries.
Methods and Findings:
We used methods recommended by the Cochrane Collaboration and GRADE approach for rating quality of evidence. In a previous review, we searched multiple databases for papers published from 1 January 1990 to 30 May 2006, and in this update, we add additional papers published from that period until 29 June 2010. We prespecified subgroups to address heterogeneity and summarized test performance using bivariate random effects meta-analysis. For pulmonary TB, we included 67 studies (48% from low- and middle-income countries) with 5,147 participants. For all tests, estimates were variable for sensitivity (0% to 100%) and specificity (31% to 100%). For anda-TB IgG, the only test with enough studies for meta-analysis, pooled sensitivity was 76% (95% CI 63%–87%) in smear-positive (seven studies) and 59% (95% CI 10%–96%) in smear-negative (four studies) patients; pooled specificities were 92% (95% CI 74%–98%) and 91% (95% CI 79%–96%), respectively. Compared with ELISA (pooled sensitivity 60% [95% CI 6%–65%]; pooled specificity 98% [95% CI 96%–99%]), immunochromatographic tests yielded lower pooled sensitivity (53%, 95% CI 42%–64%) and comparable pooled specificity (98%, 95% CI 94%–99%). For extrapulmonary TB, we included 25 studies (40% from low- and middle-income countries) with 1,809 participants. For all tests, estimates were variable for sensitivity (0% to 100%) and specificity (59% to 100%). Overall, quality of evidence was graded very low for studies of pulmonary and extrapulmonary TB.
Conclusions:
Despite expansion of the literature since 2006, commercial serological tests continue to produce inconsistent and imprecise estimates of sensitivity and specificity. Quality of evidence remains very low. These data informed a recently published World Health Organization policy statement against serological tests.
: Please see later in the article for the Editors' Summary
Zdroje
1. LonnrothKCastroKGChakayaJMChauhanLSFloydK 2010 Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375 1814 1829
2. SmallPMPaiM 2010 Tuberculosis diagnosis—time for a game change. N Engl J Med 363 1070 1071
3. HarriesA 2004 How does the diagnosis of tuberculosis in persons infected with HIV differ from diagnosis in persons not infected with HIV? FriedenT Toman's tuberculosis: case detection, treatment, and monitoring—questions and answers, 2nd ed Geneva World Health Organization 80 83
4. PerkinsMDCunninghamJ 2007 Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196 Suppl 1 S15 S27
5. SteingartKRNgVHenryMHopewellPCRamsayA 2006 Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6 664 674
6. BoehmeCCNabetaPHillemannDNicolMPShenaiS 2010 Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363 1005 1015
7. World Health Organization 2010 Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB Geneva: World Health Organization. Available: http://www.who.int/tb/laboratory/roadmap_xpert_mtb-rif.pdf. Accessed 6 March 2011
8. HopewellPCPaiMMaherDUplekarMRaviglioneMC 2006 International standards for tuberculosis care. Lancet Infect Dis 6 710 725
9. World Health Organization Special Programme for Research and Training in Tropical Diseases, Foundation for Innovative New Diagnostics 2006 Diagnostics for tuberculosis: global demand and market potential. Geneva World Health Organization Available: http://apps.who.int/tdr/svc/publications/tdr-research-publications/diagnostics-tuberculosis-global-demand. Accessed 20 June 2010
10. GrenierJPintoLNairDSteingartKRDowdyD 2011 Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Respir J. In press
11. DinnesJDeeksJKunstHGibsonACumminsE 2007 A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 11 1 196
12. SteingartKRHenryMLaalSHopewellPCRamsayA 2007 Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 4 e202 doi:10.1371/journal.pmed.0040202
13. SteingartKRHenryMLaalSHopewellPCRamsayA 2007 A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax 62 911 918
14. SteingartKRDendukuriNHenryMSchillerINahidP 2009 Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol 16 260 276
15. Special Programme for Research and Training in Tropical Diseases 2008 Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis. Geneva World Health Organization
16. LeeflangMMDeeksJJGatsonisCBossuytPM 2008 Systematic reviews of diagnostic test accuracy. Ann Intern Med 149 889 897
17. MoherDLiberatiATetzlaffJAltmanDG 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6 e1000097 doi:10.1371/journal.pmed.1000097
18. MacaskillPGatsonisCDeeksJJHarbordRMTakwoingiYT 2010 Analysying and presenting results. DeeksJJBossuytPMGatsonisC Cochrane handbook for systematic reviews of diagnostic test accuracy, version 0.9.0 London The Cochrane Collaboration Available: http://srdta.cochrane.org/Accessed 6 March 2011
19. World Bank 2010 World Bank list of economies. Washington (District of Columbia) World Bank Available: http://siteresources.worldbank.org/DATASTATISTICS/Resources/CLASS.XLS. Accessed 5 August 2010
20. AndersonBLWelchRJLitwinCM 2008 Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis. Clin Vaccine Immunol 15 1644 1649
21. WhitingPRutjesAWReitsmaJBBossuytPMKleijnenJ 2003 The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3 25
22. PaiMMinionJSteingartKRamsayA 2010 New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 16 271 284
23. SchunemannHJOxmanADBrozekJGlasziouPJaeschkeR 2008 Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 1106 1110
24. BalshemHHelfandMSchünemannHJOxmanADKunzR 2010 GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64 401 406
25. RutterCMGatsonisCA 2001 A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20 2865 2884
26. SpiegelhalterDThomasABestNLunnD 2004 WinBUGS user manual, version 1.4.1. Available: http://www.mrc-bsu.cam.ac.uk/bugs. BUGS Project. Accessed 13 May 2010
27. AlanACoullA 1998 Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 52 119 126
28. JonesCMAthanasiouT 2005 Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79 16 20
29. R Development Core Team 2006 R: a language and environment for statistical computing. Available: http://www.R-project.org. R Project for Statistical Computing. Accessed 13 May 2010
30. AlifanoMDel PezzoMLambertiCFaraoneSCovelliI 1994 ELISA method for evaluation of anti-A60 IgG in patients with pulmonary and extrapulmonary tuberculosis. New Microbiol 17 37 43
31. AlifanoMSofiaMMormileMMiccoAMormileAF 1996 IgA immune response against the mycobacterial antigen A60 in patients with active pulmonary tuberculosis. Respiration 63 292 297
32. AlifanoMDe PascalisRSofiaMFaraoneSDel PezzoM 1997 Evaluation of IgA-mediated humoral immune response against the mycobacterial antigen P-90 in diagnosis of pulmonary tuberculosis. Chest 111 601 605
33. AmicosanteMHoudeMGuaraldiGSaltiniC 1999 Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis. Int J Tuberc Lung Dis 3 736 740
34. BukharyZA 2007 Evaluation of anti-A60 antigen IgG enzyme-linked immunosorbent assay for serodiagnosis of pulmonary tuberculosis. Ann Thorac Med 2 47 51
35. ChandrasekaranSGuptaEVVChauhanMMBailyGVJChaudhuriK 1990 Serodiagnosis of pulmonary tuberculosis by kaolin agglutination test. Indian J Tuberc 37 11 15
36. CondeMBSuffysPSilvaJKritskiALDormanSE 2004 Immunoglobulin a (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 11 94 97
37. D'AlessandroAde WaardJH 2008 [Evaluation of two commercial tests for the serodiagnosis of pulmonary tuberculosis.] Rev Chilena Infectol 25 37 40
38. ErerOFBiçmenCKýraklýCAktoðuSFloratN 2001 [Diagnostic value of a rapid immunochromotographic test (ICT) in patients with active pulmonary tuberculosis.] Toraks Dergisi 2 80 84
39. GaoMQChuNHWangHYZhaoQRLiH 2007 [The clinical significance of serum tuberculosis specific antigen antibody in the diagnosis of tuberculosis.] Zhonghua Jie He He Hu Xi Za Zhi 30 918 920
40. ImazMSCominiMAZerbiniESequeiraMDLatiniO 2004 Evaluation of commercial enzyme-linked immunosorbent assay kits for detection of tuberculosis in Argentinean population. J Clin Microbiol 42 884 887
41. JulianEMatasLAlcaideJLuquinM 2004 Comparison of antibody responses to a potential combination of specific glycolipids and proteins for test sensitivity improvement in tuberculosis serodiagnosis. Clin Diagn Lab Immunol 11 70 76
42. JulianEMatasLHernandezAAlcaideJLuquinM 2000 Evaluation of a new serodiagnostic tuberculosis test based on immunoglobulin A detection against Kp-90 antigen. Int J Tuberc Lung Dis 4 1082 1085
43. KalantriYHemvaniNBhatiaGCChitnisDS 2005 Elisa kit evaluation for IgG and IgM antibodies to A-60 tubercular protein antigen. Indian J Med Sci 59 337 346
44. Kassa-KelembhoEKassaEZandangaG Service YB, Ignaleamoko A, et al. 2006 Poor performance of a novel serological test for diagnosis of pulmonary tuberculosis in Bangui, Central African Republic. Clin Vaccine Immunol 13 702 703
45. LuhKTYuCJYangPCLeeLN 1996 Tuberculosis antigen A60 serodiagnosis in tuberculous infection: application in extrapulmonary and smear-negative pulmonary tuberculosis. Respirology 1 145 151
46. MaekuraRKohnoHHirotaniAOkudaYItoM 2003 Prospective clinical evaluation of the serologic tuberculous glycolipid test in combination with the nucleic acid amplification test. J Clin Microbiol 41 1322 1325
47. MaekuraROkudaYNakagawaMHiragaTYokotaS 2001 Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis. J Clin Microbiol 39 3603 3608
48. McConkeySJYoussefFGAzemEFrenckRWWeilGJ 2002 Evaluation of a rapid-format antibody test and the tuberculin skin test for diagnosis of tuberculosis in two contrasting endemic settings. Int J Tuberc Lung Dis 6 246 252
49. MizusawaMKawamuraMTakamoriMKashiyamaTFujitaA 2008 Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis. Clin Vaccine Immunol 15 544 548
50. MukhopadhyayAGuanMChenHYLuYLimTK 2006 Prospective study of a new serological test (ASSURE TB Rapid Test) for the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 10 620 624
51. NurkicMImamovicANumanovicFGegicMOsmicM 2006 [Diagnostical values of antibody on A60 antigen in diagnostic of tuberculosis.] Med Arh 60 166 170
52. OkudaYMaekuraRHirotaniAKitadaSYoshimuraK 2004 Rapid serodiagnosis of active pulmonary Mycobacterium tuberculosis by analysis of results from multiple antigen-specific tests. J Clin Microbiol 42 1136 1141
53. OngutGOguncDGunserenFOgusCDonmezL 2006 Evaluation of the ICT Tuberculosis test for the routine diagnosis of tuberculosis. BMC Infect Dis 6 37
54. PlatonovaILSakhelashviliMI 2007 [Comparative evaluation of the informative value of the rapid serochek mbt test to determine mycobacterium tuberculosis antibodies and mantoux tuberculin test in adults.] Probl Tuberk Bolezn Legk 2007 10 13
55. SomiGRO'BrienRJMfinangaGSIpugeYA 1999 Evaluation of the MycoDot (TM) test in patients with suspected tuberculosis in a field setting in Tanzania. Inter J Tuberc Lung Dis 3 231 238
56. TraunmüllerFHaslingerILaglerHWolfgangGZeitlingerMA 2005 Influence of the washing buffer composition on the sensitivity of an enzyme-linked immunosorbent assay using mycobacterial glycolipids as capture antigens. J Immunoassay Immunochem 26 179 188
57. WilkinsonRJHaslovKRappuoliRGiovannoniFNarayananPR 1997 Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol 35 553 557
58. WuHPHuaCCYuCCWuSY 2005 Comparison of plasma interferon-gamma and antigen 60 immunoglobulin G in diagnosing pulmonary Mycobacterium tuberculosis infection. Chang Gung Med J 28 779 785
59. WuHPShiehWBHsienFKHuaCC 2004 The significance of Mycobacterium tuberculosis antibody, antigen 60 IgG in patients with abnormal chest radiography. Chang Gung Med J 27 869 876
60. AlifanoMDe PascalisRSofiaMFaraoneSDel PezzoM 1998 Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis. Thorax 53 377 380
61. BanerjeeSGuptaSShendeNKumarSHarinathBC 2003 Serodiagnosis of tuberculosis using two ELISA systems. Indian J Clin Biochem 18 48 53
62. CamineroJARodriguez de CastroFCarrilloTDiazFRodriguez BermejoJC 1993 Diagnosis of pleural tuberculosis by detection of specific IgG anti-antigen 60 in serum and pleural fluid. Respiration 60 58 62
63. CamineroJARodriguez de CastroFCarrilloTLafargaBDiazF 1994 Value of ELISA using A60 antigen in the serodiagnosis of tuberculosis. Respiration 61 283 286
64. ChierakulNDamrongchokpipatPChaiprasertAArjratanakulW 2001 Antibody detection for the diagnosis of tuberculous pleuritis. Int J Tuberc Lung Dis 5 968 972
65. GevaudanMJBolletCCharpinDMalletMNDe MiccoP 1992 Serological response of tuberculosis patients to antigen 60 of BCG. Eur J Epidemiol 8 666 676
66. KunterECerrahogluKIlvanAIsitmangilTTurkenO 2003 The value of pleural fluid anti-A60 IgM in BCG-vaccinated tuberculous pleurisy patients. Clin Microbiol Infect 9 212 220
67. NsanzeHAmeenASFaresEVargeesLMustafaN 1997 Serodiagnosis of tuberculosis and leprosy by enzyme immunoassay. Clin Microbiol Infect 3 236 239
68. RatanasuwanWKreissJKNolanCMSchaefflerBASuwanagoolS 1997 Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients. Int J Tuberc Lung Dis 1 259 264
69. SenolGErerOFYalcinYACoskunMGunduzAT 2007 Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis. Eur Respir J 29 143 148
70. BossuytPMReitsmaJBBrunsDEGatsonisCAGlasziouPP 2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138 40 44
71. LijmerJGMolBWHeisterkampSBonselGJPrinsMH 1999 Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282 1061 1066
72. RutjesAWReitsmaJBDi NisioMSmidtNvan RijnJC 2006 Evidence of bias and variation in diagnostic accuracy studies. CMAJ 174 469 476
73. HarbordRMDeeksJJEggerMWhitingPSterneJA 2007 A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8 239 251
74. Davey SmithGEggerMPhillipsAN 1997 Meta-analysis. Beyond the grand mean? BMJ 315 1610 1614
75. TatsioniAZarinDAAronsonNSamsonDJFlammCR 2005 Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 142 1048 1055
76. DowdyDWSteingartKRPaiM 2011 Serological testing versus other strategies for diagnosis of active tuberculosis in India: A cost-effectiveness analysis. PLoS Med 8 e1001074 doi:10.1371/journal.pmed.1001074
77. World Health Organization 2011 Policy Statement: Commercial serodiagnostic tests for diagnosis of tuberculosis. WHO, Geneva, Switzerland. WHO/HTM/TB/2011.5. Available: http://www.who.int/tb/laboratory/policy_statement/en. Accessed 12 July 2011
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 8
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Commercial Serological Tests for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis: An Updated Systematic Review and Meta-Analysis
- Are HIV Epidemics among Men Who Have Sex with Men Emerging in the Middle East and North Africa?: A Systematic Review and Data Synthesis
- Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis
- Being the Ghost in the Machine: A Medical Ghostwriter's Personal View